← 產業報告目錄
Oxcarbazepine Tablets Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 148報告編號 APO-09c53cbb70
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Oxcarbazepine Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oxcarbazepine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oxcarbazepine Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Oxcarbazepine Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oxcarbazepine Tablets include ANI Pharmaceuticals, Apotex, Glenmark Pharmaceuticals, Hikma Pharmaceuticals, Jamp Pharma, Jubilant Generics, Neuraxpharm, Nexgen pharma and Nobelpharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oxcarbazepine Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oxcarbazepine Tablets Market by Company
ANI Pharmaceuticals
Apotex
Glenmark Pharmaceuticals
Hikma Pharmaceuticals
Jamp Pharma
Jubilant Generics
Neuraxpharm
Nexgen pharma
Nobelpharma
Novartis (Trileptal)
Orion Corporation
Roxane Laboratories
Stada Group
Sun Pharm
Supernus Pharmaceuticals (Oxtellar XR)
Taro Pharmaceuticals
Teva Pharmaceutical
Huikang Pharmaceutical
Mylan
Humanwell Healthcare
SihuanPharm
Oxcarbazepine Tablets Segment by Type
Tablets (150mg)
Tablets (300mg)
Tablets (600mg)
Oxcarbazepine Tablets Segment by Application
Retail Pharmacy
Hospital Pharmacy
Online Pharmacy
Oxcarbazepine Tablets Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxcarbazepine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxcarbazepine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxcarbazepine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oxcarbazepine Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oxcarbazepine Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oxcarbazepine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Oxcarbazepine Tablets Market Size (2021-2032)
2.2.2 Global Oxcarbazepine Tablets Sales (2021-2032)
2.2.3 Global Oxcarbazepine Tablets Market Average Price (2021-2032)
2.3 Oxcarbazepine Tablets by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Tablets (150mg)
2.3.3 Tablets (300mg)
2.3.4 Tablets (600mg)
2.4 Oxcarbazepine Tablets by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Retail Pharmacy
2.4.3 Hospital Pharmacy
2.4.4 Online Pharmacy
3 Market Competitive Landscape by Manufacturers
3.1 Global Oxcarbazepine Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Oxcarbazepine Tablets Sales (K Units) of Manufacturers (2021-2026)
3.3 Global Oxcarbazepine Tablets Revenue of Manufacturers (2021-2026)
3.4 Global Oxcarbazepine Tablets Average Price by Manufacturers (2021-2026)
3.5 Global Oxcarbazepine Tablets Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Oxcarbazepine Tablets, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Oxcarbazepine Tablets, Product Type & Application
3.8 Global Manufacturers of Oxcarbazepine Tablets, Established Date
3.9 Global Oxcarbazepine Tablets Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 ANI Pharmaceuticals
4.1.1 ANI Pharmaceuticals Company Information
4.1.2 ANI Pharmaceuticals Business Overview
4.1.3 ANI Pharmaceuticals Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.1.4 ANI Pharmaceuticals Oxcarbazepine Tablets Product Portfolio
4.1.5 ANI Pharmaceuticals Recent Developments
4.2 Apotex
4.2.1 Apotex Company Information
4.2.2 Apotex Business Overview
4.2.3 Apotex Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Apotex Oxcarbazepine Tablets Product Portfolio
4.2.5 Apotex Recent Developments
4.3 Glenmark Pharmaceuticals
4.3.1 Glenmark Pharmaceuticals Company Information
4.3.2 Glenmark Pharmaceuticals Business Overview
4.3.3 Glenmark Pharmaceuticals Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Glenmark Pharmaceuticals Oxcarbazepine Tablets Product Portfolio
4.3.5 Glenmark Pharmaceuticals Recent Developments
4.4 Hikma Pharmaceuticals
4.4.1 Hikma Pharmaceuticals Company Information
4.4.2 Hikma Pharmaceuticals Business Overview
4.4.3 Hikma Pharmaceuticals Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Hikma Pharmaceuticals Oxcarbazepine Tablets Product Portfolio
4.4.5 Hikma Pharmaceuticals Recent Developments
4.5 Jamp Pharma
4.5.1 Jamp Pharma Company Information
4.5.2 Jamp Pharma Business Overview
4.5.3 Jamp Pharma Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Jamp Pharma Oxcarbazepine Tablets Product Portfolio
4.5.5 Jamp Pharma Recent Developments
4.6 Jubilant Generics
4.6.1 Jubilant Generics Company Information
4.6.2 Jubilant Generics Business Overview
4.6.3 Jubilant Generics Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Jubilant Generics Oxcarbazepine Tablets Product Portfolio
4.6.5 Jubilant Generics Recent Developments
4.7 Neuraxpharm
4.7.1 Neuraxpharm Company Information
4.7.2 Neuraxpharm Business Overview
4.7.3 Neuraxpharm Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Neuraxpharm Oxcarbazepine Tablets Product Portfolio
4.7.5 Neuraxpharm Recent Developments
4.8 Nexgen pharma
4.8.1 Nexgen pharma Company Information
4.8.2 Nexgen pharma Business Overview
4.8.3 Nexgen pharma Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Nexgen pharma Oxcarbazepine Tablets Product Portfolio
4.8.5 Nexgen pharma Recent Developments
4.9 Nobelpharma
4.9.1 Nobelpharma Company Information
4.9.2 Nobelpharma Business Overview
4.9.3 Nobelpharma Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Nobelpharma Oxcarbazepine Tablets Product Portfolio
4.9.5 Nobelpharma Recent Developments
4.10 Novartis (Trileptal)
4.10.1 Novartis (Trileptal) Company Information
4.10.2 Novartis (Trileptal) Business Overview
4.10.3 Novartis (Trileptal) Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Novartis (Trileptal) Oxcarbazepine Tablets Product Portfolio
4.10.5 Novartis (Trileptal) Recent Developments
4.11 Orion Corporation
4.11.1 Orion Corporation Company Information
4.11.2 Orion Corporation Business Overview
4.11.3 Orion Corporation Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Orion Corporation Oxcarbazepine Tablets Product Portfolio
4.11.5 Orion Corporation Recent Developments
4.12 Roxane Laboratories
4.12.1 Roxane Laboratories Company Information
4.12.2 Roxane Laboratories Business Overview
4.12.3 Roxane Laboratories Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Roxane Laboratories Oxcarbazepine Tablets Product Portfolio
4.12.5 Roxane Laboratories Recent Developments
4.13 Stada Group
4.13.1 Stada Group Company Information
4.13.2 Stada Group Business Overview
4.13.3 Stada Group Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Stada Group Oxcarbazepine Tablets Product Portfolio
4.13.5 Stada Group Recent Developments
4.14 Sun Pharm
4.14.1 Sun Pharm Company Information
4.14.2 Sun Pharm Business Overview
4.14.3 Sun Pharm Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Sun Pharm Oxcarbazepine Tablets Product Portfolio
4.14.5 Sun Pharm Recent Developments
4.15 Supernus Pharmaceuticals (Oxtellar XR)
4.15.1 Supernus Pharmaceuticals (Oxtellar XR) Company Information
4.15.2 Supernus Pharmaceuticals (Oxtellar XR) Business Overview
4.15.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Product Portfolio
4.15.5 Supernus Pharmaceuticals (Oxtellar XR) Recent Developments
4.16 Taro Pharmaceuticals
4.16.1 Taro Pharmaceuticals Company Information
4.16.2 Taro Pharmaceuticals Business Overview
4.16.3 Taro Pharmaceuticals Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.16.4 Taro Pharmaceuticals Oxcarbazepine Tablets Product Portfolio
4.16.5 Taro Pharmaceuticals Recent Developments
4.17 Teva Pharmaceutical
4.17.1 Teva Pharmaceutical Company Information
4.17.2 Teva Pharmaceutical Business Overview
4.17.3 Teva Pharmaceutical Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.17.4 Teva Pharmaceutical Oxcarbazepine Tablets Product Portfolio
4.17.5 Teva Pharmaceutical Recent Developments
4.18 Huikang Pharmaceutical
4.18.1 Huikang Pharmaceutical Company Information
4.18.2 Huikang Pharmaceutical Business Overview
4.18.3 Huikang Pharmaceutical Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.18.4 Huikang Pharmaceutical Oxcarbazepine Tablets Product Portfolio
4.18.5 Huikang Pharmaceutical Recent Developments
4.19 Mylan
4.19.1 Mylan Company Information
4.19.2 Mylan Business Overview
4.19.3 Mylan Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.19.4 Mylan Oxcarbazepine Tablets Product Portfolio
4.19.5 Mylan Recent Developments
4.20 Humanwell Healthcare
4.20.1 Humanwell Healthcare Company Information
4.20.2 Humanwell Healthcare Business Overview
4.20.3 Humanwell Healthcare Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.20.4 Humanwell Healthcare Oxcarbazepine Tablets Product Portfolio
4.20.5 Humanwell Healthcare Recent Developments
4.21 SihuanPharm
4.21.1 SihuanPharm Company Information
4.21.2 SihuanPharm Business Overview
4.21.3 SihuanPharm Oxcarbazepine Tablets Sales, Revenue and Gross Margin (2021-2026)
4.21.4 SihuanPharm Oxcarbazepine Tablets Product Portfolio
4.21.5 SihuanPharm Recent Developments
5 Global Oxcarbazepine Tablets Market Scenario by Region
5.1 Global Oxcarbazepine Tablets Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Oxcarbazepine Tablets Sales by Region: 2021-2032
5.2.1 Global Oxcarbazepine Tablets Sales by Region: 2021-2026
5.2.2 Global Oxcarbazepine Tablets Sales by Region: 2027-2032
5.3 Global Oxcarbazepine Tablets Revenue by Region: 2021-2032
5.3.1 Global Oxcarbazepine Tablets Revenue by Region: 2021-2026
5.3.2 Global Oxcarbazepine Tablets Revenue by Region: 2027-2032
5.4 North America Oxcarbazepine Tablets Market Facts & Figures by Country
5.4.1 North America Oxcarbazepine Tablets Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Oxcarbazepine Tablets Sales by Country (2021-2032)
5.4.3 North America Oxcarbazepine Tablets Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.5 Europe Oxcarbazepine Tablets Market Facts & Figures by Country
5.5.1 Europe Oxcarbazepine Tablets Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Oxcarbazepine Tablets Sales by Country (2021-2032)
5.5.3 Europe Oxcarbazepine Tablets Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.5.9 Nordic Countries
5.6 Asia Pacific Oxcarbazepine Tablets Market Facts & Figures by Country
5.6.1 Asia Pacific Oxcarbazepine Tablets Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Oxcarbazepine Tablets Sales by Country (2021-2032)
5.6.3 Asia Pacific Oxcarbazepine Tablets Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Oxcarbazepine Tablets Market Facts & Figures by Country
5.7.1 South America Oxcarbazepine Tablets Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Oxcarbazepine Tablets Sales by Country (2021-2032)
5.7.3 South America Oxcarbazepine Tablets Revenue by Country (2021-2032)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Oxcarbazepine Tablets Market Facts & Figures by Country
5.8.1 Middle East and Africa Oxcarbazepine Tablets Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Oxcarbazepine Tablets Sales by Country (2021-2032)
5.8.3 Middle East and Africa Oxcarbazepine Tablets Revenue by Country (2021-2032)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Oxcarbazepine Tablets Sales by Type (2021-2032)
6.1.1 Global Oxcarbazepine Tablets Sales by Type (2021-2032) & (K Units)
6.1.2 Global Oxcarbazepine Tablets Sales Market Share by Type (2021-2032)
6.2 Global Oxcarbazepine Tablets Revenue by Type (2021-2032)
6.2.1 Global Oxcarbazepine Tablets Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Oxcarbazepine Tablets Revenue Market Share by Type (2021-2032)
6.3 Global Oxcarbazepine Tablets Price by Type (2021-2032)
7 Segment by Application
7.1 Global Oxcarbazepine Tablets Sales by Application (2021-2032)
7.1.1 Global Oxcarbazepine Tablets Sales by Application (2021-2032) & (K Units)
7.1.2 Global Oxcarbazepine Tablets Sales Market Share by Application (2021-2032)
7.2 Global Oxcarbazepine Tablets Revenue by Application (2021-2032)
7.2.1 Global Oxcarbazepine Tablets Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Oxcarbazepine Tablets Revenue Market Share by Application (2021-2032)
7.3 Global Oxcarbazepine Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Oxcarbazepine Tablets Value Chain Analysis
8.1.1 Oxcarbazepine Tablets Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Oxcarbazepine Tablets Production Mode & Process
8.2 Oxcarbazepine Tablets Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Oxcarbazepine Tablets Distributors
8.2.3 Oxcarbazepine Tablets Customers
9 Global Oxcarbazepine Tablets Analyzing Market Dynamics
9.1 Oxcarbazepine Tablets Industry Trends
9.2 Oxcarbazepine Tablets Industry Drivers
9.3 Oxcarbazepine Tablets Industry Opportunities and Challenges
9.4 Oxcarbazepine Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Oxcarbazepine Tablets Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Oxcarbazepine Tablets Sales (K Units) of Manufacturers (2021-2026)
Table 7. Global Oxcarbazepine Tablets Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Oxcarbazepine Tablets Revenue of Manufacturers (2021-2026)
Table 9. Global Oxcarbazepine Tablets Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Oxcarbazepine Tablets Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Oxcarbazepine Tablets Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Oxcarbazepine Tablets, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Oxcarbazepine Tablets, Product Type & Application
Table 14. Global Oxcarbazepine Tablets Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Oxcarbazepine Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. ANI Pharmaceuticals Company Information
Table 19. ANI Pharmaceuticals Business Overview
Table 20. ANI Pharmaceuticals Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. ANI Pharmaceuticals Oxcarbazepine Tablets Product Portfolio
Table 22. ANI Pharmaceuticals Recent Developments
Table 23. Apotex Company Information
Table 24. Apotex Business Overview
Table 25. Apotex Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Apotex Oxcarbazepine Tablets Product Portfolio
Table 27. Apotex Recent Developments
Table 28. Glenmark Pharmaceuticals Company Information
Table 29. Glenmark Pharmaceuticals Business Overview
Table 30. Glenmark Pharmaceuticals Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. Glenmark Pharmaceuticals Oxcarbazepine Tablets Product Portfolio
Table 32. Glenmark Pharmaceuticals Recent Developments
Table 33. Hikma Pharmaceuticals Company Information
Table 34. Hikma Pharmaceuticals Business Overview
Table 35. Hikma Pharmaceuticals Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. Hikma Pharmaceuticals Oxcarbazepine Tablets Product Portfolio
Table 37. Hikma Pharmaceuticals Recent Developments
Table 38. Jamp Pharma Company Information
Table 39. Jamp Pharma Business Overview
Table 40. Jamp Pharma Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Jamp Pharma Oxcarbazepine Tablets Product Portfolio
Table 42. Jamp Pharma Recent Developments
Table 43. Jubilant Generics Company Information
Table 44. Jubilant Generics Business Overview
Table 45. Jubilant Generics Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. Jubilant Generics Oxcarbazepine Tablets Product Portfolio
Table 47. Jubilant Generics Recent Developments
Table 48. Neuraxpharm Company Information
Table 49. Neuraxpharm Business Overview
Table 50. Neuraxpharm Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. Neuraxpharm Oxcarbazepine Tablets Product Portfolio
Table 52. Neuraxpharm Recent Developments
Table 53. Nexgen pharma Company Information
Table 54. Nexgen pharma Business Overview
Table 55. Nexgen pharma Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. Nexgen pharma Oxcarbazepine Tablets Product Portfolio
Table 57. Nexgen pharma Recent Developments
Table 58. Nobelpharma Company Information
Table 59. Nobelpharma Business Overview
Table 60. Nobelpharma Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. Nobelpharma Oxcarbazepine Tablets Product Portfolio
Table 62. Nobelpharma Recent Developments
Table 63. Novartis (Trileptal) Company Information
Table 64. Novartis (Trileptal) Business Overview
Table 65. Novartis (Trileptal) Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Novartis (Trileptal) Oxcarbazepine Tablets Product Portfolio
Table 67. Novartis (Trileptal) Recent Developments
Table 68. Orion Corporation Company Information
Table 69. Orion Corporation Business Overview
Table 70. Orion Corporation Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Orion Corporation Oxcarbazepine Tablets Product Portfolio
Table 72. Orion Corporation Recent Developments
Table 73. Roxane Laboratories Company Information
Table 74. Roxane Laboratories Business Overview
Table 75. Roxane Laboratories Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Roxane Laboratories Oxcarbazepine Tablets Product Portfolio
Table 77. Roxane Laboratories Recent Developments
Table 78. Stada Group Company Information
Table 79. Stada Group Business Overview
Table 80. Stada Group Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Stada Group Oxcarbazepine Tablets Product Portfolio
Table 82. Stada Group Recent Developments
Table 83. Sun Pharm Company Information
Table 84. Sun Pharm Business Overview
Table 85. Sun Pharm Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Sun Pharm Oxcarbazepine Tablets Product Portfolio
Table 87. Sun Pharm Recent Developments
Table 88. Supernus Pharmaceuticals (Oxtellar XR) Company Information
Table 89. Supernus Pharmaceuticals (Oxtellar XR) Business Overview
Table 90. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Tablets Product Portfolio
Table 92. Supernus Pharmaceuticals (Oxtellar XR) Recent Developments
Table 93. Taro Pharmaceuticals Company Information
Table 94. Taro Pharmaceuticals Business Overview
Table 95. Taro Pharmaceuticals Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Taro Pharmaceuticals Oxcarbazepine Tablets Product Portfolio
Table 97. Taro Pharmaceuticals Recent Developments
Table 98. Teva Pharmaceutical Company Information
Table 99. Teva Pharmaceutical Business Overview
Table 100. Teva Pharmaceutical Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Teva Pharmaceutical Oxcarbazepine Tablets Product Portfolio
Table 102. Teva Pharmaceutical Recent Developments
Table 103. Huikang Pharmaceutical Company Information
Table 104. Huikang Pharmaceutical Business Overview
Table 105. Huikang Pharmaceutical Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Huikang Pharmaceutical Oxcarbazepine Tablets Product Portfolio
Table 107. Huikang Pharmaceutical Recent Developments
Table 108. Mylan Company Information
Table 109. Mylan Business Overview
Table 110. Mylan Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Mylan Oxcarbazepine Tablets Product Portfolio
Table 112. Mylan Recent Developments
Table 113. Humanwell Healthcare Company Information
Table 114. Humanwell Healthcare Business Overview
Table 115. Humanwell Healthcare Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Humanwell Healthcare Oxcarbazepine Tablets Product Portfolio
Table 117. Humanwell Healthcare Recent Developments
Table 118. SihuanPharm Company Information
Table 119. SihuanPharm Business Overview
Table 120. SihuanPharm Oxcarbazepine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. SihuanPharm Oxcarbazepine Tablets Product Portfolio
Table 122. SihuanPharm Recent Developments
Table 123. Global Oxcarbazepine Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 124. Global Oxcarbazepine Tablets Sales by Region (2021-2026) & (K Units)
Table 125. Global Oxcarbazepine Tablets Sales Market Share by Region (2021-2026)
Table 126. Global Oxcarbazepine Tablets Sales by Region (2027-2032) & (K Units)
Table 127. Global Oxcarbazepine Tablets Sales Market Share by Region (2027-2032)
Table 128. Global Oxcarbazepine Tablets Revenue by Region (2021-2026) & (US$ Million)
Table 129. Global Oxcarbazepine Tablets Revenue Market Share by Region (2021-2026)
Table 130. Global Oxcarbazepine Tablets Revenue by Region (2027-2032) & (US$ Million)
Table 131. Global Oxcarbazepine Tablets Revenue Market Share by Region (2027-2032)
Table 132. North America Oxcarbazepine Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 133. North America Oxcarbazepine Tablets Sales by Country (2021-2026) & (K Units)
Table 134. North America Oxcarbazepine Tablets Sales by Country (2027-2032) & (K Units)
Table 135. North America Oxcarbazepine Tablets Revenue by Country (2021-2026) & (US$ Million)
Table 136. North America Oxcarbazepine Tablets Revenue by Country (2027-2032) & (US$ Million)
Table 137. Europe Oxcarbazepine Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 138. Europe Oxcarbazepine Tablets Sales by Country (2021-2026) & (K Units)
Table 139. Europe Oxcarbazepine Tablets Sales by Country (2027-2032) & (K Units)
Table 140. Europe Oxcarbazepine Tablets Revenue by Country (2021-2026) & (US$ Million)
Table 141. Europe Oxcarbazepine Tablets Revenue by Country (2027-2032) & (US$ Million)
Table 142. Asia Pacific Oxcarbazepine Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 143. Asia Pacific Oxcarbazepine Tablets Sales by Country (2021-2026) & (K Units)
Table 144. Asia Pacific Oxcarbazepine Tablets Sales by Country (2027-2032) & (K Units)
Table 145. Asia Pacific Oxcarbazepine Tablets Revenue by Country (2021-2026) & (US$ Million)
Table 146. Asia Pacific Oxcarbazepine Tablets Revenue by Country (2027-2032) & (US$ Million)
Table 147. South America Oxcarbazepine Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 148. South America Oxcarbazepine Tablets Sales by Country (2021-2026) & (K Units)
Table 149. South America Oxcarbazepine Tablets Sales by Country (2027-2032) & (K Units)
Table 150. South America Oxcarbazepine Tablets Revenue by Country (2021-2026) & (US$ Million)
Table 151. South America Oxcarbazepine Tablets Revenue by Country (2027-2032) & (US$ Million)
Table 152. Middle East and Africa Oxcarbazepine Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 153. Middle East and Africa Oxcarbazepine Tablets Sales by Country (2021-2026) & (K Units)
Table 154. Middle East and Africa Oxcarbazepine Tablets Sales by Country (2027-2032) & (K Units)
Table 155. Middle East and Africa Oxcarbazepine Tablets Revenue by Country (2021-2026) & (US$ Million)
Table 156. Middle East and Africa Oxcarbazepine Tablets Revenue by Country (2027-2032) & (US$ Million)
Table 157. Global Oxcarbazepine Tablets Sales by Type (2021-2026) & (K Units)
Table 158. Global Oxcarbazepine Tablets Sales by Type (2027-2032) & (K Units)
Table 159. Global Oxcarbazepine Tablets Sales Market Share by Type (2021-2026)
Table 160. Global Oxcarbazepine Tablets Sales Market Share by Type (2027-2032)
Table 161. Global Oxcarbazepine Tablets Revenue by Type (2021-2026) & (US$ Million)
Table 162. Global Oxcarbazepine Tablets Revenue by Type (2027-2032) & (US$ Million)
Table 163. Global Oxcarbazepine Tablets Revenue Market Share by Type (2021-2026)
Table 164. Global Oxcarbazepine Tablets Revenue Market Share by Type (2027-2032)
Table 165. Global Oxcarbazepine Tablets Price by Type (2021-2026) & (US$/Unit)
Table 166. Global Oxcarbazepine Tablets Price by Type (2027-2032) & (US$/Unit)
Table 167. Global Oxcarbazepine Tablets Sales by Application (2021-2026) & (K Units)
Table 168. Global Oxcarbazepine Tablets Sales by Application (2027-2032) & (K Units)
Table 169. Global Oxcarbazepine Tablets Sales Market Share by Application (2021-2026)
Table 170. Global Oxcarbazepine Tablets Sales Market Share by Application (2027-2032)
Table 171. Global Oxcarbazepine Tablets Revenue by Application (2021-2026) & (US$ Million)
Table 172. Global Oxcarbazepine Tablets Revenue by Application (2027-2032) & (US$ Million)
Table 173. Global Oxcarbazepine Tablets Revenue Market Share by Application (2021-2026)
Table 174. Global Oxcarbazepine Tablets Revenue Market Share by Application (2027-2032)
Table 175. Global Oxcarbazepine Tablets Price by Application (2021-2026) & (US$/Unit)
Table 176. Global Oxcarbazepine Tablets Price by Application (2027-2032) & (US$/Unit)
Table 177. Key Raw Materials
Table 178. Raw Materials Key Suppliers
Table 179. Oxcarbazepine Tablets Distributors List
Table 180. Oxcarbazepine Tablets Customers List
Table 181. Oxcarbazepine Tablets Industry Trends
Table 182. Oxcarbazepine Tablets Industry Drivers
Table 183. Oxcarbazepine Tablets Industry Restraints
Table 184. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Oxcarbazepine Tablets Product Image
Figure 5. Global Oxcarbazepine Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Oxcarbazepine Tablets Market Size (2021-2032) & (US$ Million)
Figure 7. Global Oxcarbazepine Tablets Sales (2021-2032) & (K Units)
Figure 8. Global Oxcarbazepine Tablets Average Price (US$/Unit) & (2021-2032)
Figure 9. Tablets (150mg) Product Image
Figure 10. Tablets (300mg) Product Image
Figure 11. Tablets (600mg) Product Image
Figure 12. Retail Pharmacy Product Image
Figure 13. Hospital Pharmacy Product Image
Figure 14. Online Pharmacy Product Image
Figure 15. Global Oxcarbazepine Tablets Revenue Share by Manufacturers in 2025
Figure 16. Global Manufacturers of Oxcarbazepine Tablets, Manufacturing Sites & Headquarters
Figure 17. Global Top 5 and 10 Oxcarbazepine Tablets Players Market Share by Revenue in 2025
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 19. Global Oxcarbazepine Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 20. Global Oxcarbazepine Tablets Sales by Region in 2025
Figure 21. Global Oxcarbazepine Tablets Revenue by Region in 2025
Figure 22. North America Oxcarbazepine Tablets Market Size by Country in 2025
Figure 23. North America Oxcarbazepine Tablets Sales Market Share by Country (2021-2032)
Figure 24. North America Oxcarbazepine Tablets Revenue Market Share by Country (2021-2032)
Figure 25. United States Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Canada Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Europe Oxcarbazepine Tablets Market Size by Country in 2025
Figure 28. Europe Oxcarbazepine Tablets Sales Market Share by Country (2021-2032)
Figure 29. Europe Oxcarbazepine Tablets Revenue Market Share by Country (2021-2032)
Figure 30. Germany Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. France Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. U.K. Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Italy Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Netherlands Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Nordic Countries Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Asia Pacific Oxcarbazepine Tablets Market Size by Country in 2025
Figure 37. Asia Pacific Oxcarbazepine Tablets Sales Market Share by Country (2021-2032)
Figure 38. Asia Pacific Oxcarbazepine Tablets Revenue Market Share by Country (2021-2032)
Figure 39. China Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Japan Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. South Korea Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. India Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Australia Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. China Taiwan Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Southeast Asia Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Southeast Asia Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. South America Oxcarbazepine Tablets Market Size by Country in 2025
Figure 48. South America Oxcarbazepine Tablets Sales Market Share by Country (2021-2032)
Figure 49. South America Oxcarbazepine Tablets Revenue Market Share by Country (2021-2032)
Figure 50. Mexico Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Brazil Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Argentina Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. Middle East and Africa Oxcarbazepine Tablets Market Size by Country in 2025
Figure 54. Middle East and Africa Oxcarbazepine Tablets Sales Market Share by Country (2021-2032)
Figure 55. Middle East and Africa Oxcarbazepine Tablets Revenue Market Share by Country (2021-2032)
Figure 56. Turkey Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Saudi Arabia Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. UAE Oxcarbazepine Tablets Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Global Oxcarbazepine Tablets Sales Market Share by Type (2021-2032)
Figure 60. Global Oxcarbazepine Tablets Revenue Market Share by Type (2021-2032)
Figure 61. Global Oxcarbazepine Tablets Price (US$/Unit) by Type (2021-2032)
Figure 62. Global Oxcarbazepine Tablets Sales Market Share by Application (2021-2032)
Figure 63. Global Oxcarbazepine Tablets Revenue Market Share by Application (2021-2032)
Figure 64. Global Oxcarbazepine Tablets Price (US$/Unit) by Application (2021-2032)
Figure 65. Oxcarbazepine Tablets Value Chain
Figure 66. Oxcarbazepine Tablets Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Oxcarbazepine Tablets Industry Opportunities and Challenges
提及公司
ANI PharmaceuticalsApotexGlenmark PharmaceuticalsHikma PharmaceuticalsJamp PharmaJubilant GenericsNeuraxpharmNexgen pharmaNobelpharmaNovartis (Trileptal)Orion CorporationRoxane LaboratoriesStada GroupSun PharmSupernus Pharmaceuticals (Oxtellar XR)Taro PharmaceuticalsTeva PharmaceuticalHuikang PharmaceuticalMylanHumanwell HealthcareSihuanPharm
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們